International Clinical Trial: A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% in Patients With Mild to Moderate Atopic Dermatitis Over 8 Weeks

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07519174) titled 'A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% in Patients With Mild to Moderate Atopic Dermatitis Over 8 Weeks' on April 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).

Primary Sponsor: Foundation University Islamabad

Condition: Atopic Dermatitis

Intervention: Drug: Tacrolimus

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: June 1, 2026

Target Sample Size: 72

Countries of Recruitmen...